Parkinson’s Disease Treatment Market to Exhibit Impressive Growth During 2022– 2030: Grand View Research Inc.

 Parkinson’s Disease Treatment Market Growth & Trends

The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson’s Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson’s Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson’s Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.

Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.

For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.

Request a free sample copy or view report summary: Parkinson’s Disease Treatment Market Report

Parkinson’s Disease Treatment Market Report Highlights

• By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment
• The retail pharmacy distribution channel segment dominated the global industry in 2021
• This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart
• Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market
• In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan

Access Press Release@ https://www.grandviewresearch.com/press-release/global-parkinsons-disease-treatment-market

Parkinson’s Disease Treatment Market Segmentation

Grand View Research has segmented the global Parkinson’s disease treatment market on the basis of drug class, distribution channel, and region:

Parkinson’s Disease Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• Carbidopa-levodopa
• Dopamine Agonists
• MAO-B Inhibitors
• COMT Inhibitors
• Anticholinergics
• Others

Parkinson’s Disease Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Parkinson’s Disease Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Parkinson’s Disease Treatment Market

• Cerevel Therapeutics
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• GlaxoSmithKline plc. (GSK)
• AbbVie, Inc.
• Lundbeck A/S
• Amneal Pharmaceuticals LLC
• Supernus Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Saliva Collection And Diagnostics Market to Reflect Robust Expansion During 2022-2030: Grand View Research Inc.

 Saliva Collection And Diagnostics Market Growth & Trends

The global saliva collection and diagnostics market size is expected to reach USD 1.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.4% over the forecast period owing to the increasing prevalence of communicable and non-communicable diseases along with the increasing preference for non-invasive methods for disease diagnosis. Moreover, the growing need to diagnose COVID-19-infected symptomatic and asymptomatic patients have created significant opportunities for the market. In August 2022, a research study published in PLOS ONE stated that oral fluid samples could be used for various diagnostic assays, such as COVID-19, due to its storage and ease of sample collection. Moreover, researchers have also stated that even if the salivary samples were stored for more than 28 days, it would remain reliable and useful.

Furthermore, the global burden of cancer and related deaths rose in 2020, majorly because of the increasing aging population and socioeconomic development. In April 2020, an article published in the American Society of clinical oncology stated that more than 50% of cancers globally are diagnosed in people aged 65 and older. Therefore, the saliva-based test is considered to be the best non-invasive procedure to detect cancer. In August 2022, OrisDX announced of developing a saliva-based non-invasive molecular test to diagnose and detect oral cancer at an early stage which would help in improving patient outcomes.

There has been significant growth in the adoption of saliva samples for both clinical and research applications as it offers non-invasive sampling, easy, simple collection, and higher patient compliance, among others. Several advancements and developments are happening in saliva specimens which would advance the proteomics field. For instance, in September 2022, an article published in India Today stated that researchers from IIT Roorkee identified salivary proteins which could help in predicting metastatic triple-negative breast cancer.

Key players operating in the market are taking several initiatives such as entering into strategic alliances and launching new products which are contributing to the overall growth. For instance, in January 2021, OraSure Technologies, Inc. announced that its saliva collection device, OMNIgene·ORAL, has been selected by Chronomics Limited for the SARS CoV-2 PCR test. Similarly, in August 2020, Fluidigm Corporation announced receiving FDA authorization for its saliva-based test, Advanta Dx SARS-CoV-2 RT-PCR assay. This test would help to detect the presence of coronavirus in the sample.

Request a free sample copy or view report summary: Saliva Collection And Diagnostics Market Report

Saliva Collection And Diagnostics Market Report Highlights

• The growth of the overall saliva collection and diagnostics market is attributed to the increasing prevalence of infectious diseases along with the growing demand for non-invasive methods for disease detection
• By site of collection, the submandibular/sublingual gland collection segment dominated the market in 2021, owing to the increasing cases of sialoliths among the young population
• By application, the disease diagnostics segment dominated the market in 2021 owing to the increasing aging population globally coupled with increasing cases of diseases such as cancer, cardiovascular diseases, and others
• By end use, the diagnostic laboratories segment captured the highest market share in 2021, owing to the growing number of diagnostic labs along with the introduction of advanced technology which could help in the early detection of diseases
• By region, North America dominated the market in 2021 owing to the presence of several market players along with increasing support from the government to boost the demand in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-saliva-collection-diagnostics-market

Saliva Collection And Diagnostics Market Segmentation

Grand View Research has segmented the global saliva collection and diagnostics market on the basis of site of collection, application, end-use, and region:

Saliva Collection And Diagnostics Site of Collection Outlook (Revenue, USD Million, 2018 - 2030)

• Parotid Gland Collection
• Submandibular/Sublingual Gland Collection
• Others

Saliva Collection And Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Disease Diagnostics
• Forensic Applications
• Research

Saliva Collection And Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Dentistry
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes

Saliva Collection And Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players Of Saliva Collection And Diagnostics Market

• Thermo Fisher Scientific, Inc.
• Neogen Corporation
• Abbott
• Sarstedt AG & Co.KG
• Autogen, Inc.
• Oasis Diagnostics
• Porex
• Salimetrics, LLC
• Takara Bio, Inc.
• Arcis Bio
• Orasure Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personalized Medicine Market Projected To Be Worth $922.72 Billion By 2030: Grand View Research Inc.

 Personalized Medicine Market Growth & Trends

The global personalized medicine market size is expected to reach USD 922.72 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.95% from 2022 to 2030 owing to the increasing incidence of diseases and the rising demand for novel therapeutic drugs. The emerging applications of personalized medicine are consistently enhanced by immense research efforts. For instance, in July 2022, researchers at the UMass Chan Medical School developed a microorganism-based personalized medicine model system to aid the understanding of variation in metabolism to gauge the connection between an individual’s genome, diet, microbiota, and associative environmental factors.

Most cancer conditions are usually caused by an underlying genetic discrepancy and can cause fatalities with progression. The cancer condition can be effectively and precisely treated by understanding specific genomic characteristics. For instance, in May 2020, Qiagen launched QIAseq pan-cancer multi-modal panel to enable robust analysis of genomic characteristics of cancer subjects to derive a broad spectrum of applications in precision medicine for the profiling of solid tumors and heme malignancies.

The market is positively driven by advancements in NGS technologies and extensive research on the human genome. There has been an increasing focus on utilizing NGS to derive personalized medicine outcomes that could potentially be used for the treatment of cancer and rare genetic disorders. For instance, Illumina declared that it will present its multiple oncology research abstracts at the European Society of Medical Oncology (ESMO) annual meeting in Paris. Their research enables personalized cancer care using comprehensive genomic profiling of biopsies to match subjects to the potential drugs and immunotherapies.

Telemedicine facilitates virtual or telephonic clinical advice to aid physical convenience. Telemedicine is increasingly trending, especially after the COVID-19 pandemic. Government and research institutes are taking substantial efforts to enhance the applications of personalized telemedicine. For instance, in August 2022, the National Cancer Institute declared a grant of USD 23 million for five years to aid the launch of Telehealth Research Centers of Excellence (TRACE) across the U.S. The program was launched with the support of the White House Cancer Moonshot to seek development and advancements in telehealth delivery for cancer care with a mission to leverage health equity.

Molecular imaging systems and medical devices are playing a primary role in emerging advancements in personalized medicine. They effectively leverage the applications of personalized medicine in the treatment of different types of cancers. For instance, in June 2022, GE Healthcare declared the release of high-end molecular imaging by using gallium-68 radioisotope for the diagnosis and monitoring of prostate cancer so as to leverage access to precision health and theranostics for personalized prostate cancer treatment at an early stage of cancer progression.

The market is in the growth phase due to emerging technological advancements along with consistent industrial efforts such as collaborations and expansions. For instance, in December 2021, Biogen Inc., and TheraPanacea declared that they have signed a collaboration that focuses on advancing digital health for personalized medicine in neuroscience.

Request a free sample copy or view report summary: Personalized Medicine Market Report

Personalized Medicine Market Report Highlights

• The overall growth of the market is attributed to the rising need for novel therapeutic drugs coupled with leveraged genetic level understanding of diseases and the rising incidence of cancers and genetic disorders across the globe
• The personalized medicine therapeutics segment is anticipated to witness high growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals. Further, the genomic medicine therapeutics segment is anticipated to grow substantially during the forecast period owing to significantly lowered costs of whole-genome sequencing
• North America dominated the market in 2021 due to the presence of key players and their intensive research for the development of novel therapies to find out curative solutions for various diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/global-personalized-medicine-market

Personalized Medicine Market Segmentation

Grand View Research has segmented the global personalized medicine market on the basis of product and region:

Personalized Medicine Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Personalized Medicine Diagnostics
  • Genetic Testing
  • Direct-To-Consumer (DTC) Diagnostics
  • Esoteric Lab Services
  • Esoteric Lab Tests
• Personalized Medicine Therapeutics
  • Pharmaceutical
  • Genomic Medicine
  • Medical Devices
• Personalized Medical Care
  • Telemedicine
  • Health Information Technology
• Personalized Nutrition & Wellness
  • Retail Nutrition
  • Complementary & Alternative Medicine

Personalized Medicine Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Personalized Medicine Market

• GE Healthcare
• Illumina, Inc.
• ASURAGEN, INC.
• Abbott
• Dako A/S
• Exact Sciences Corporation
• Danaher Corporation (Cepheid, Inc.)
• Decode Genetics, Inc.
• QIAGEN
• Exagen Inc.
• Precision Biologics
• Celera Diagnostics LLC
• Biogen
• Genelex
• International Business Machines Corporation (IBM)
• Genentech, Inc.
• 23andMe, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antimicrobial Resistance Diagnostics Market Latest Trends, Industry Growth And Forecast To 2030: Grand View Research Inc.

 Antimicrobial Resistance Diagnostics Market Growth & Trends

The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies’ efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Request a free sample copy or view report summary: Antimicribial Resistance Diagnostics Market Report

Antimicrobial Resistance Diagnostics Market Report Highlights

• PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements
• Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches
• In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections
• In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antimicrobial-resistance-diagnostics-market

Antimicrobial Resistance Diagnostics Market Segmentation

Grand View Research has segmented the global antimicrobial resistance diagnostics market based on technology, pathogen, end user, and region:

Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Microbiology Culture
• Immunoassay
• PCR
• NGS
• Mass Spectrometry
• Rapid & Point of Care
• Others

Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Resistant Streptococcus Pneumoniae (DRSP)
• Drug Resistant Campylobacter (DRC)
• Clostridium Difficile (CD)
• Methicillin Resistant Staphylococcus Aureus (MRSA)
• Drug Resistant Neisseria Gonorrhoeae (DRNG)
• Drug Resistant Salmonella (DRNTS)
• Others

Antimicrobial Resistance Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Antimicrobial Resistance Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Antimicrobial Resistance Diagnostics Market

• bioMerieux
• Hoffmann-La Roche Ltd.
• Abbott
• Hologic, Inc.
• BD
• Danaher
• Accelerate Diagnostics, Inc.
• Molsid
• Vela Diagnostics
• Visby Medical, Inc.
• OpGen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Postpartum Products Market Predicted to Witness Steady Growth During the Forecast Period

 

Postpartum Products Market Growth & Trends

The global postpartum products market size is expected to reach USD 3.90 billion by 2030, registering a CAGR of 6.5% according to a new report by Grand View Research, Inc. A rise in the pregnancy rate globally is expected to boost the demand for postpartum products. These products help to deal with the physical changes of pregnant women post-pregnancy. However, the economic crisis caused by COVID-19 in many countries across the globe has led to a considerable decline in birth rates. For instance, a survey by the National Academy of Sciences in Europe showed that 73.0% of those planning to have a child in 2020 decided to delay or abandoned their plans entirely. This is expected to impact the market growth in the long term.

The growing burden of problems during pregnancy, especially in developing countries, is likely to upsurge the adoption of postpartum products in such countries. As per the WHO, in 2017, approximately 810 women died every day from pregnancy and childbirth. In addition, the rising awareness among consumers regarding the use of safer and more effective post-partum solutions is anticipated to propel the market growth over the forecast period.

Moreover, the presence of various e-commerce sites offering postpartum products might drive the sales of the products through this sales channel over the forecast period. Motherhood Maternity, The Moms Co., Amazon, Walmart, Babylist, and Buy Buy Baby are some of the notable e-commerce sites that offer significant discounts and prompt customer service on various postpartum products owing to which people prefer to shop via the online sites.

Request a free sample copy or view the report summary: Postpartum Products Market Report

Postpartum Products Market Report Highlights

• Based on product, the breastfeeding accessories segment dominated the market with a revenue share of over 55.0% in 2020 owing to the growing awareness among new mothers regarding the benefits of postpartum products
• Based on sales channel, the hospital pharmacy (inpatient) segment dominated the market with a revenue share of over 35.0% in 2020 due to the easy availability of a wide range of postpartum products. Moreover, hospital pharmacists help consumers in seeking advice, which is an added advantage
• Asia Pacific dominated the market with a revenue share of over 40.0% in 2020. The rising awareness level, coupled with the presence of a large population in this region, is expected to boost the demand for postpartum products over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-postpartum-products-market

Postpartum Products Market Segmentation

Grand View Research has segmented the global postpartum products market based on product and sales channel:

Postpartum Products Outlook (Revenue, USD Million, 2018 - 2030)

• Breastfeeding Accessories
  • Breast Pads
  • Nipple Care Products
  • Breast Shells
  • Breastmilk Preparation & Cleaning Products
  • Breastmilk Storage & Feeding
  • Other Accessories
• Perineal Cooling Pads
• Others

Postpartum Products Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy (Inpatient)
• Retail Store
• E-commerce
• Wholesaler/Distributor
• Direct Purchase

Postpartum Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Postpartum Products Market

• Koninklijke Philips N.V.
• Medela LLC
• Newell Brands
• Ameda
• NUBY
• Mayborn Group Limited
• Edge well Personal Care
• Handi-craft Company (Dr. Brown’s)
• Artsana S.P.A
• Medline

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sugar Substitutes Market to Witness Exponential Growth by 2030: Grand View Research Inc.

 Sugar Substitutes Market Growth & Trends

The global sugar substitutes market size is expected to reach USD 10.42 billion by 2030, registering a CAGR of 5.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. Growing consumer inclination toward low-calorie foods and beverages, particularly in developing countries, are expected to propel the industry growth during the forecast period. In addition, increasing demand for immunity boosters and less-sugary products owing to the rising consumer awareness to improve their general health and well-being is expected to accelerate the industry growth. COVID-19 had forced governments to impose lockdowns, due to which more than half of people's physical activity had been reduced.

Moreover, eating has also become more common when people are binge-watching television shows at home, and in response to various types of mental stress. Individuals are increasingly concerned regarding their health as a consequence of COVID-19 casualties; this factor influenced them to seek low-calorie sugar food items. Sugar substitutes, such as tagatose, aspartame saccharine, and sorbitol are widely used in the food & beverage, healthcare, and cosmetics industries. The rising use of sugar substitutes in frozen foods, confectioneries, bakeries, and dairy is expected to benefit the industry. The increased incidences of health problems associated with sugar intake, such as diabetes and obesity, in developing markets are driving industry growth.

Furthermore, sugar substitutes are expected to benefit from fluctuating supply as well as the pricing of sugar. The market for low-calorie, plant-based, and naturally sweet ingredients has grown, with stevia and monk fruit being high-intensity plant-based sweeteners certified by FDA GRAS. Furthermore, global demand for natural and clean-label food products is increasing as consumers have become more aware of the adverse health consequences of using artificial ingredients. According to a report by the Food & Health Survey, approximately 74% of U.S. consumers avoided sugar in their diets in 2020. In addition, the number of new product innovations emphasizing plant-based products to combat rising obesity is increasing significantly.

Request a free sample copy or view the report summary: Sugar Substitutes Market Report

Sugar Substitutes Market Report Highlights

• The high-intensity sweeteners segment held the largest revenue share in 2021 as only small quantities are required to produce the equivalent sweetness as regular sugar
• The beverage application segment dominated the global industry in 2021 due to the rising demand for low-calorie sports and health drinks among consumers
• Asia Pacific is estimated to register the second-fastest growth rate during the forecast period owing to the rising number of diabetic patients in developing countries like India and China
• Europe is anticipated to witness a rapid growth rate during the forecast period owing to the presence of numerous businesses that produce sugar substitutes, including Roquette Freres, Tate & Lyle, and E. I. DuPont De Nemours, among others
• The region is also seeing a rise in the use of sugar substitutes due to the rising number of diabetic patients
• According to the World Health Organization (WHO), around 60 million people in the European Region, or 9.6% of women and 10.3% of men aged 25 years and over, have diabetes

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sugar-substitutes-market

Sugar Substitutes Market Segmentation

Grand View Research has segmented the global sugar substitutes market based on type, application, and region:

Sugar Substitute Type Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• High-intensity Sweeteners
  • Natural
    • Stevia Extracts
    • Licorice Root Extracts
    • Monk Fruit Extracts
  • Artificial
    • Aspartame
    • Cyclamate
    • Saccharin
    • Sucralose
    • Others
  • Low-intensity Sweeteners
    • Xylitol
    • Sorbitol
    • Maltitol
    • Mannitol
    • Trehalose
    • Isomaltulose
    • Others
  • High Fructose Syrup

Sugar Substitute Application Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• Food
  • Bakery
  • Confectionery
  • Dairy
  • Others
• Beverages
  • Juices
  • Functional Drinks
  • Carbonated Drinks
  • Non-Dairy
  • Milk and Dairy
  • Others
• Health & Personal Care

Sugar Substitute Regional Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Mexico
  • RONA
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Indonesia
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Turkey
  • South Africa

List of Key Players in Sugar Substitutes Market

• Tate & Lyle
• Cargill, Inc.
• Archer Daniels Midland Company (ADM)
• Ingredion Inc.
• Roquette Freres
• Ajinomoto Co.
• JK Sucralose Inc.
• The NutraSweet Company
• PureCircle
• I. DuPont De Nemours

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mattress Market Is Expected To Gain Significant Traction Over The Forecast Period: Grand View Research Inc.

 Mattress Market Growth & Trends

The global mattress market size is expected to reach USD 67.5 billion by 2030, registering a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. Increasing cases of back problems associated with uncomfortable sleeping surfaces are boosting the demand for innerspring mattresses. Another major factor driving the segment growth is the improving condition of the housing market, along with enhanced purchasing power parity across the globe. The rapidly growing real estate industry, coupled with a rise in residential and personal spaces including apartments, and houses among others across the globe, is fueling the product demand. The majority of the consumers reported that they would consider making huge purchases for the household because of a considerable amount of time spent at home, which made them notice various aspects that might need to be updated or are missing.

In terms of value, the foam mattress segment dominated the industry and will account for the largest revenue share by 2030. Memory foam is widely used in the commercial sector, especially in hospitals, as it offers several benefits. Memory foam molds as per the body in response to heat and pressure, thereby evenly distributing body weight. The design technique of memory foam mattresses is such that it returns to their original shape once the pressure is removed. North America held the second-largest share in 2021 owing to an increased number of home renovation activities that include personalizing according to recent trends and consumer needs.

For instance, according to a remodeling survey from the National Association of Home Builders, 40% of the houses in North America are more than 50 years old anticipating there will be an increase in renovation spending in the coming years. Manufacturing these products requires low capital investment, and thus, a number of players are entering the market. This has led to price competitiveness in the industry. With changing buying behavior of consumers, premium mattresses including memory foam and latex mattresses have also been experiencing traction among consumers. In addition, increasing cases of severe back problems, mainly caused by uncomfortable sleeping surfaces, are likely to play a vital role in boosting the demand for specialty mattresses, such as airbeds, waterbeds, and foam-based mattresses.

Request a free sample copy or view report summary: Mattress Market Report

Mattress Market Report Highlights

• The foam segment led the industry in 2021 owing to the increased preference for these products in the domestic and commercial sectors
• The queen-size mattress segment led the industry in 2021 on account of the low cost of these products. Moreover, these mattresses provide more sleeping space than single- & double-size mattresses
• The household segment is expected to register the fastest CAGR from 2022 to 2030 due to the increasing availability of premium mattress products with numerous functional benefits
• The online distribution channel segment is expected to witness a substantial growth rate over the forecast period
• According to a blog by Sleepyhead in 2022, manufacturers are providing novel offerings, like a 100-night free trial, which would have been unthinkable a decade ago if consumers wanted to buy a mattress without going through the retail experience. Due to this strategy, buyers feel confident while purchasing mattresses online
• Asia Pacific was the largest region in 2021 and is expected to register a considerable CAGR over the forecast period due to changing lifestyles according to the recent trends in home décor

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mattress-market

Mattress Market Segmentation

Grand View Research has segmented the global mattress market on the basis of type, size, end-use, distribution channel, and region:

Mattress Type Outlook (Revenue, USD Million, 2017 - 2030)

• Innerspring
• Foam
• Hybrid
• Others

Mattress Size Outlook (Revenue, USD Million, 2017 - 2030)

• Single
• Double
• Queen
• King

Mattress End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Household
• Commercial

Mattress Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Mattress Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players of Mattress Market

• Tempur Sealy International, Inc.
• Serta Simmons Bedding LLC
• Spring Air International
• Sleep Number Corp.
• Kingsdown, Inc.
• Southerland Sleep
• Boll & Branch
• Casper Sleep Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Metagenomics Market is Expected to Enhance USD 4.87 Billion Revenue By 2030: Grand View Research Inc.

 Metagenomics Market Growth & Trends

The global metagenomics market size is expected to reach USD 4.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 14.4% from 2022 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Request a free sample copy or view report summary: Metagenomics Market Report

Metagenomics Market Report Highlights

• By product, the kits & reagents segment accounts for the largest market share. The demand in terms of volumes is high for these products. High market penetration of kits and reagents further contributes toward their highest revenue share
• By technology, the shotgun sequencing segment is estimated to have the largest share with the fastest CAGR over the forecast period. The advantages such as the ability to read all genomic DNA in a sample give a competitive edge to the technology resulting in the growing adoption of shotgun sequencing among researchers
• By application, the clinical diagnostics segment is anticipated to have the fastest CAGR throughout the forecast period. Owing to the research initiatives for the development of personalized therapies using sequencing technology are expected to impact growth in the area of clinical research, hence, propelling the growth
• By workflow, the sequencing segment held the largest share in 2021, owing to the adoption of easy workflow models, demand for rapid results, and lower cost of per sample analysis compared to the price of systems driving the demand for sequencing & data analytics services
• North America dominated the global metagenomics industry in 2021 owing to the presence of well-established marketing and distribution network of major companies and large-sized research & academic institutes, which focus on genomic studies
• A few of the key players include Illumina. Inc.; Thermo Fisher Scientific, Inc.; QIAGEN; and Promega Corporation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-metagenomics-market

Metagenomics Market Segmentation

Grand View Research has segmented the global metagenomics market based on product, technology, workflow, application, and region:

Metagenomics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Kits & Reagents
• Sequencing & Data Analytics Services
• Software

Metagenomics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Shotgun Sequencing
• 16S Sequencing
• Whole Genome Sequencing
• Others

Metagenomics Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Pre-sequencing
• Sequencing
• Data Analysis

Metagenomics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Environmental
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Food & Nutrition
• Others

Metagenomics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Metagenomics Market

• Bio-Rad Laboratories
• Illumina, Inc.
• PerkinElmer, Inc. 
• Thermo Fisher Scientific, Inc.
• Novogene Co., Ltd.
• Promega Corporation
• QIAGEN
• Takara Bio, Inc.
• Oxford Nanopore Technologies
• Hoffmann-La Roche Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vegan Food Market is Estimated To Attain USD 37.45 Billion by 2030

 Vegan Food Market Growth & Trends

The global vegan food market size was estimated to reach USD 37.45 billion in 2030 and is anticipated to expand at a CAGR of 10.6% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising consumer preference for plant-based food owing to the growing animal cruelty and awareness regarding the health benefits of a vegan diet are the major factors expected to drive the industry’s growth. However, high prices of vegan foods owing to their expensive manufacturing process are anticipated to hamper the growth.

The growth of the global vegan food industry is supported by growing veganism across the globe. Vegan food helps improve metabolism as it is rich in fiber. This has resulted in its increasing adoption which is anticipated to fuel the growth of the industry. Moreover, increasing initiatives by key players to launch plant-based food in both developed and developing countries are fueling market growth during the forecast period.

The meat & seafood segment is expected to register the fastest CAGR during the forecast period. The significant presence and high demand for plant-based meat in developing countries are expected to drive the growth of the segment. The availability of a variety of meat categories coupled with the availability of a wide range of plant-based meat products including deli slices, meatballs, tenders, chicken nuggets, and others is driving the growth.

The offline distribution channel led the market and is estimated to continue dominating during the forecast period. The high share is attributed to the easy accessibility of offline stores. Products from different brands are easily available in one place in offline stores resulting in their higher purchase. Moreover, offline distribution channels such as convenience stores, supermarkets, hypermarkets, and others provide the facility of physical verification of the product, which is further expected to drive segment growth.

North America accounted for the largest revenue share in 2021. The growing number of campaigns on social media regarding vegan food adoption by celebrities such as Jake Gyllenhaal and Serena Williams is driving the market growth. Moreover, the increasing demand and adoption of dairy alternatives among consumers owing to the high presence of lactose intolerant population in the region is a key factor contributing to the growth.

Major industry players include Amy's Kitchen; Danone S.A; Daiya Foods Inc.; Beyond Meat; Tofutti Brands Inc.; Plamil Foods Ltd; VBites Foods Limited; Eden Foods Inc.; VITASOY International Holdings Limited; and SunOpta. Various steps are adopted by these companies including global expansion, partnerships, acquisitions & mergers, development & launch of new products, and others to gain a larger market share.

Request a free sample copy or view the report summary: Vegan Food Market Report

Vegan Food Market Report Highlights

• Asia Pacific is expected to register the fastest CAGR over the forecast period owing to the growing demand for plant-based food and rising health consciousness among consumers
• The yogurt segment is estimated to grow at the second highest CAGR over the forecast period. The rising preference for dairy-free products among millennials is expected to drive the segment’s growth
• The vegan cheese segment is expected to expand at a significant CAGR over the forecast period. The increasing consumption of vegan cheese by lactose intolerant consumers is anticipated to contribute to the growth of the segment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vegan-food-market

Vegan Food Market Segmentation

Grand View Research has segmented the global vegan food market based on product, distribution channel, and region:

Vegan Food Product Outlook (Revenue, USD Million, 2017 - 2030)

• Meat & Seafood
• Creamer
• Ice Cream and Frozen Novelties
• Yogurt
• Cheese
• Butter
• Meals
• Protein Bars
• Others

Vegan Food Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Vegan Food Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in Vegan Food Market

• Amy's Kitchen
• Danone S.A
• Daiya Foods Inc.
• Beyond Meat
• Tofutti Brands Inc.
• Plamil Foods Ltd
• VBites Foods Limited
• Eden Foods Inc.
• VITASOY International Holdings Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.